ACTRN12617000799358
Recruiting
Phase 2
A randomised controlled clinical trial to evaluate the incidence and severity of oxygen desaturation events when using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to oxygenate paediatric patients undergoing microlaryngoscopy and bronchoscopy
Overview
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 250
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- o limit to 13 Years (—)
- Sex
- All
Inclusion Criteria
- •The principal inclusion criteria are male and female patients under the age of 13 years who are undergoing Microlaryngoscopy and Bronchoscopy.
Exclusion Criteria
- •Exclusion criteria are patients with a BMI (body mass index) greater than 35, severe nasal obstruction, patients with defects within the anterior skull base, inability to obtain informed parental consent, and emergency MLB when the time from being informed about the trial and time of surgery is less than 24 hours.
- •Children undergoing laser, diathermy or other forms of treatment associated with fires on or around their airway.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A clinical study to compare effect of kushmand choornavati with Tagar ghanvati as anxiolytic and sedative as pre-medication in spinal anaesthesiaHealth Condition 1: F409- Phobic anxiety disorder, unspecifiedCTRI/2020/01/022835PDEAS College of Ayurved and research centre
Not yet recruiting
Not Applicable
A clinical trial to study the effects of two procedures, shatpushpa siddha taila nasya and shatpushpa siddha taila matrabasti in patients with irregular menses and pcos.Health Condition 1: E282- Polycystic ovarian syndromeCTRI/2024/03/063784Chaitalee Rajendra Jain
Terminated
Phase 3
Varenicline alone or with nicotine e-cigarettes for smoking cessation in people with mental illness and drug and/or alcohol dependence.SmokingMental illnessDrug and alcohol dependenceMental Health - AddictionMental Health - Other mental health disordersACTRN12616001355460The University of Auckland15
Completed
Not Applicable
A randomised controlled clinical trial to evaluate the anti-osteolytic agent clodronate for the prevention of the development of bone metastases in patients with primary breast cancerISRCTN83688026Royal Marsden Hospital (UK), secondary sponsor Schering (Germany)1,000
Completed
Not Applicable
High dose fluconazole with or without flucytosine in the treatment of human immunodeficiency virus (HIV)-associated cryptococcal meningitiscryptococcal meningitisCryptococcal meningitis/ HIVInfections and InfestationsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesISRCTN02725351St George's University of London (UK)80